Searching News Database: Sofinnova Ventures
HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
HSMN NewsFeed - 7 Nov 2019
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
HSMN NewsFeed - 1 Oct 2018
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
HSMN NewsFeed - 25 Apr 2018
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
HSMN NewsFeed - 6 Jan 2016
NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
HSMN NewsFeed - 21 Jul 2015
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
HSMN NewsFeed - 6 Apr 2015
Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing
Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing
HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
HSMN NewsFeed - 19 Aug 2014
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
HSMN NewsFeed - 15 May 2014
Sorbent Therapeutics Closes First Tranche Of $15 Million Series D Financing
Sorbent Therapeutics Closes First Tranche Of $15 Million Series D Financing
HSMN NewsFeed - 7 Jan 2013
RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals
RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals
HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
HSMN NewsFeed - 30 Jun 2011
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
HSMN NewsFeed - 12 Oct 2010
Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
HSMN NewsFeed - 26 May 2010
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
HSMN NewsFeed - 29 Jul 2009
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
HSMN NewsFeed - 13 Aug 2008
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
HSMN NewsFeed - 19 Mar 2008
Bifurcated Stent Company Stentys Completes $18 Million 'Series B' Venture Financing
Bifurcated Stent Company Stentys Completes $18 Million 'Series B' Venture Financing
HSMN NewsFeed - 3 Mar 2008
Pfizer Names William Ringo Senior Vice President of Strategy and Business Development
Pfizer Names William Ringo Senior Vice President of Strategy and Business Development
HSMN NewsFeed - 27 Feb 2008
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
HSMN NewsFeed - 16 Apr 2007
Diobex Raises $24 Million Series B Financing Led by Inventages Venture Capital
Diobex Raises $24 Million Series B Financing Led by Inventages Venture Capital
HSMN NewsFeed - 26 Feb 2007
Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
HSMN NewsFeed - 13 Sep 2006
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
Additional items found! 21
Members Archive contains
21 additional stories matching:
Sofinnova Ventures
(Password required)
Sofinnova Ventures
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!